| Members |
targetComponentId |
| Adverse reaction to antiallergic and antiemetic drugs NOS |
Adverse reaction to antihistamines |
| Adverse reaction to antidotes and chelating agents NEC |
Chelating agent adverse reaction |
| Adverse reaction to antilipemic and anti-arteriosclerotic drugs |
Lipid-lowering drug adverse reaction |
| Adverse reaction to antilymphocyte immunoglobulin |
Antineoplastic/immunosuppressant/immunostim adverse reaction |
| Adverse reaction to benzodiazepine-based tranquilizer (finding) |
Adverse reaction to benzodiazepine |
| Adverse reaction to benzodiazepine-based tranquilizer NOS (disorder) |
Adverse reaction to benzodiazepine |
| Adverse reaction to butyrophenone-based tranquilizer (finding) |
Butyrophenone adverse reaction (disorder) |
| Adverse reaction to central nervous system depressants and anesthetics NOS |
Anesthetics adverse reaction (disorder) |
| Adverse reaction to clofibrate |
Clofibrate adverse reaction |
| Adverse reaction to combined estrogens and progestogens |
Adverse reaction to estrogen and/or progesterone (disorder) |
| Adverse reaction to coronary vasodilator |
Vasodilator adverse reaction |
| Adverse reaction to cotrimoxazole |
Adverse reaction to sulfamethoxazole and/or trimethoprim (disorder) |
| Adverse reaction to dietetics |
Intravenous nutrition adverse reaction |
| Adverse reaction to dietetics |
Adverse reaction to food |
| Adverse reaction to dietetics |
Centrally acting appetite suppressant adverse reaction |
| Adverse reaction to drugs: [antirheumatics] or [NSAID] |
Non-steroidal anti-inflammatory drug adverse reaction (disorder) |
| Adverse reaction to drugs: [antirheumatics] or [NSAID] |
Adverse reaction to antirheumatic |
| Adverse reaction to electrolytic, caloric and water balance drugs |
Foods, vitamins, electrolytes inorganic salts adverse reaction |
| Adverse reaction to erythromycin |
Allergy to erythromycin |
| Adverse reaction to erythromycin |
Hypersensitivity to erythromycin |
| Adverse reaction to erythromycin |
Erythromycin adverse reaction (disorder) |
| Adverse reaction to ethanolamine oleate |
Ethanolamine adverse reaction |
| Adverse reaction to ether |
Adverse reaction to inhaled anesthetic with ether structure |
| Adverse reaction to eye anti-infectives and other eye drugs |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
| Adverse reaction to eye drugs NOS |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
| Adverse reaction to ferric salts |
Iron adverse reaction (disorder) |
| Adverse reaction to heavy metal anti-infectives |
Bismuth chelate adverse reaction |
| Adverse reaction to hormones and synthetic substances NOS |
Adverse reaction to hormone |
| Adverse reaction to hormones and synthetic substitutes |
Adverse reaction to hormone |
| Adverse reaction to hydantoin derivatives NOS |
Adverse reaction to hydantoin and/or hydantoin derivative (disorder) |
| Adverse reaction to hydrocortisone |
Hypersensitivity to hydrocortisone (finding) |
| Adverse reaction to hydrocortisone |
Hydrocortisone adverse reaction (disorder) |
| Adverse reaction to hydrocortisone |
Allergy to hydrocortisone (finding) |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to antidiabetic drug |
| Adverse reaction to insulins and antidiabetic agents |
Insulin adverse reaction |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to biguanide oral hypoglycaemic agent |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to sulfonyluric hypoglycemic (disorder) |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to sulfonyluric hypoglycemic (disorder) |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to antidiabetic drug |
| Adverse reaction to insulins and antidiabetic agents |
Adverse reaction to biguanide oral hypoglycaemic agent |
| Adverse reaction to insulins and antidiabetic agents |
Insulin adverse reaction |
| Adverse reaction to insulins and antidiabetic agents NOS |
Adverse reaction to biguanide oral hypoglycaemic agent |
| Adverse reaction to insulins and antidiabetic agents NOS |
Insulin adverse reaction |
| Adverse reaction to insulins and antidiabetic agents NOS |
Adverse reaction to sulfonyluric hypoglycemic (disorder) |
| Adverse reaction to insulins and antidiabetic agents NOS |
Adverse reaction to antidiabetic drug |
| bivirkning af intravenøs ernæring (elektrolytter/sporstoffer) |
Intravenous nutrition adverse reaction |
| Adverse reaction to iodine or iodide |
Iodine compounds adverse reaction |
| Adverse reaction to iodine or iodide |
Iodine adverse reaction |
| Adverse reaction to iron and iron compounds |
Iron adverse reaction (disorder) |
| Adverse reaction to iron dextran injection |
Iron adverse reaction (disorder) |
| Adverse reaction to local anti-infectives and anti-inflammatory drugs |
Anti-infectives adverse reaction (disorder) |
| Adverse reaction to mercury compound |
Mercurial diuretic adverse reaction |
| Adverse reaction to minocycline |
Hypersensitivity to minocycline (finding) |
| Adverse reaction to minocycline |
Minocycline adverse reaction (disorder) |
| Adverse reaction to minocycline |
Allergy to minocycline |
| Adverse reaction to neomycin sulfate |
Neomycin adverse reaction |
| Adverse reaction to ovarian hormones and synthetic substitutes |
Sex hormones adverse reaction |
| Adverse reaction to parasympatholytic or spasmolytic NOS |
Antimuscarinic adverse reaction |
| Adverse reaction to parathyroid and parathyroid derivatives NOS |
Adverse reaction to parathyroid hormone and/or parathyroid hormone derivative |
| Adverse reaction to parathyroid hormone agent |
Adverse reaction to parathyroid hormone and/or parathyroid hormone derivative |
| Adverse reaction to pentamidine isethionate |
Pentamidine adverse reaction |
| Adverse reaction to pharmaceutical excipients |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
| Adverse reaction to phenothiazine-based tranquilizer (finding) |
Phenothiazine adverse reaction |
| Adverse reaction to psychostimulant |
Adverse reaction to caffeine |
| Adverse reaction to sedatives and hypnotics |
Sedative adverse reaction |
| Adverse reaction to sympatholytic NOS |
Adverse reaction to adrenergic receptor antagonist |
| Adverse reaction to thyroid and thyroid derivatives |
Adverse reaction to thyroid hormone |
| Adverse reaction to thyroid and thyroid derivatives NOS |
Adverse reaction to thyroid hormone |
| Adverse reaction to vaccine constituent |
Vaccine adverse reaction |
| Adverse reaction to vaccine or biological substance NOS |
Vaccine adverse reaction |
| Adverse reaction to vitamin D |
Adverse reaction to vitamin D and/or vitamin D derivative |
| Adverse reaction to vitamin K |
Adverse reaction to vitamin K and/or vitamin K derivative (disorder) |
| Adverse reaction to vitamin K NOS |
Adverse reaction to vitamin K and/or vitamin K derivative (disorder) |
| Adverse reaction to water, mineral and uric acid metabolism drugs |
Uricosuric agent adverse reaction (disorder) |
| Adverse reaction to water, mineral and uric acid metabolism drugs |
Foods, vitamins, electrolytes inorganic salts adverse reaction |
| Adverse reaction to zinc salt |
Zinc adverse reaction |
| Adverse reaction; [salicylates] or [aspirin] |
Aspirin adverse reaction |
| Adverse reaction; [salicylates] or [aspirin] |
Adverse reaction to salicylate |
| Advertising (& [executive]) &/or public relations |
Advertising/public relations |
| Advertising (& [executive]) &/or public relations |
Advertising/public relations |
| Advertising (& [executive]) &/or public relations |
Advertising executive |
| Advertising (& [executive]) &/or public relations |
Advertising executive |
| Advice |
Procedure that is synonymous with those activities such as teaching, demonstration, instruction, explanation, and advice that aim to increase knowledge and skills, change behaviors, assist coping and increase adherence to treatment. |
| Advice |
Psychosocial procedure that involves listening, reflecting, etc. to facilitate recognition of course of action / solution. |
| Advice |
Psychosocial procedure that involves listening, reflecting, etc. to facilitate recognition of course of action / solution. |
| Advice |
Procedure that is synonymous with those activities such as teaching, demonstration, instruction, explanation, and advice that aim to increase knowledge and skills, change behaviors, assist coping and increase adherence to treatment. |
| Advice |
Psychosocial procedure that involves listening, reflecting, etc. to facilitate recognition of course of action / solution. |
| Advice |
Procedure that is synonymous with those activities such as teaching, demonstration, instruction, explanation, and advice that aim to increase knowledge and skills, change behaviors, assist coping and increase adherence to treatment. |
| Advice about equipment |
Assistive device education (procedure) |
| Advice about equipment |
Durable medical equipment education, guidance, and counseling (procedure) |
| Rådgivning om observationer og fund |
Disease process or condition education |
| Rådgivning om observationer og fund |
Investigation results education (procedure) |
| Advice about use of appliances |
Assistive device education (procedure) |
| Advice about weight |
Weight control education |
| Advice about weight |
Weight control education |
| Rådgivning om vægt |
Weight control education |
| Rådgivning vedrørende fertilitet og infertilitet |
Fertility education (procedure) |
| Rådgivning vedrørende fertilitet og infertilitet |
Infertility care education |
| Advice on over-the-counter medication |
Medication education |
| Advice on smoking |
Smoking cessation education (procedure) |
| Advice relating to equipment and appliances |
Durable medical equipment education, guidance, and counseling (procedure) |
FHIR